Havas to handle Adams Respiratory media planning

NEW YORK Adams Respiratory Therapeutics, recently acquired by Reckitt Benckiser, has shifted its media planning and buying account to Havas’ Media Planning Group, Adweek reported last week.

According to the report, Adams spent more than $85 million promoting Mucinex and Delsym last year, up from $65 million in 2006.